This downturn is different.
Youssef Sebban interview by Carol Massar and Tim Stenovec on Bloomberg Businessweek.Listen Now
Insights, news, commentary and interviews about the life sciences, healthcare and tech world.
Covering life science innovation, market analysis and investment strategy.
Where is Big Pharma placing its bets? The upcoming ~$200B patent cliff and the stormy market conditions have significantly increased the pressure on Big Pharma to sustain pipelines while controlling costs. Most of the industry majors slashed their R&D budgets in 2022.Read Report
Commercialization is key.Read the article.